KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Short-term Investments (2016 - 2025)

Biogen (BIIB) has 16 years of Short-term Investments data on record, last reported at $97.6 million in Q3 2025.

  • For Q3 2025, Short-term Investments changed N/A year-over-year to $97.6 million; the TTM value through Sep 2025 reached $97.6 million, changed N/A, while the annual FY2022 figure was $1.5 billion, 4.39% down from the prior year.
  • Short-term Investments reached $97.6 million in Q3 2025 per BIIB's latest filing, down from $3.5 billion in the prior quarter.
  • Across five years, Short-term Investments topped out at $3.5 billion in Q2 2023 and bottomed at $97.6 million in Q3 2025.
  • Average Short-term Investments over 4 years is $1.6 billion, with a median of $1.5 billion recorded in 2022.
  • Peak YoY movement for Short-term Investments: plummeted 32.63% in 2021, then skyrocketed 64.37% in 2022.
  • A 4-year view of Short-term Investments shows it stood at $1.5 billion in 2021, then decreased by 4.39% to $1.5 billion in 2022, then surged by 134.85% to $3.5 billion in 2023, then crashed by 97.18% to $97.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Short-term Investments were $97.6 million in Q3 2025, $3.5 billion in Q2 2023, and $2.1 billion in Q1 2023.